DS
ARA

David Shaw’s American Renal Associates Holdings, Inc ARA Stock Holding History

David Shaw’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46,941
Closed -$537K – 4686
2020
Q4 		$537K Sell
46,941
-30,724
-40% -$350K ﹤0.01% 3356
2020
Q3 		$536K Sell
77,665
-29,191
-27% -$192K ﹤0.01% 3196
2020
Q2 		$697K Buy
106,856
+16,899
+19% +$109K ﹤0.01% 3156
2020
Q1 		$595K Buy
89,957
+3,928
+5% +$34.2K ﹤0.01% 3114
2019
Q4 		$892K Sell
86,029
-1,125
-1% -$9.62K ﹤0.01% 3065
2019
Q3 		$551K Buy
+87,154
New +$650K ﹤0.01% 3171

David Shaw's ARA Position: Q1 2021 in Review

David Shaw sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 46,941 shares — an estimated $537K sold.

David Shaw first reported a position in ARA in Q3 2019 and held it in 6 quarters. The position peaked at $892K in Q4 2019. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • David Shaw reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • David Shaw sold 46,941 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $537K.
  • David Shaw first reported a position in American Renal Associates Holdings, Inc in Q3 2019 and held it in 6 quarters.
  • David Shaw's American Renal Associates Holdings, Inc position peaked at $892K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.